Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
SkinBioTherapeutics PLC- Skin health-focused life sciences company - Says pretax loss widens to £1.2 million in six months to December 31, from £628,241 a year earlier. US market penetration with its only product launched in October 2021, AxisBiotix-Ps, for treating Psoriasis, was slower than expected, company adds. Revenue for the half comes in at £21,949, against none a year earlier. For the financial year ending in June, the company expects revenue materially below expectations, it warns.
Current stock price: 37.27 pence, down 18% on Tuesday
12-month change: down 21%
Copyright 2022 Alliance News Limited. All Rights Reserved.